nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—Colitis—Azathioprine—systemic scleroderma	0.0212	0.0212	CcSEcCtD
Bisacodyl—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0201	0.0201	CcSEcCtD
Bisacodyl—Colitis—Leflunomide—systemic scleroderma	0.0201	0.0201	CcSEcCtD
Bisacodyl—Colitis—Mycophenolic acid—systemic scleroderma	0.0191	0.0191	CcSEcCtD
Bisacodyl—Immune system disorder—Pentoxifylline—systemic scleroderma	0.0152	0.0152	CcSEcCtD
Bisacodyl—Colitis—Mycophenolate mofetil—systemic scleroderma	0.0151	0.0151	CcSEcCtD
Bisacodyl—Muscle spasms—Pentoxifylline—systemic scleroderma	0.0141	0.0141	CcSEcCtD
Bisacodyl—Cramp muscle—Leflunomide—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Bisacodyl—Dehydration—Mycophenolic acid—systemic scleroderma	0.0135	0.0135	CcSEcCtD
Bisacodyl—Angioedema—Pentoxifylline—systemic scleroderma	0.0134	0.0134	CcSEcCtD
Bisacodyl—Abdominal discomfort—Azathioprine—systemic scleroderma	0.0133	0.0133	CcSEcCtD
Bisacodyl—Immune system disorder—Mometasone—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Bisacodyl—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.013	0.013	CcSEcCtD
Bisacodyl—Dehydration—Lisinopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Bisacodyl—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.0119	0.0119	CcSEcCtD
Bisacodyl—Shock—Pentoxifylline—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Bisacodyl—Cramp muscle—Lisinopril—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Bisacodyl—Angioedema—Mometasone—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Bisacodyl—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Bisacodyl—Anaphylactic shock—Mometasone—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Bisacodyl—Angioedema—Captopril—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Bisacodyl—Immune system disorder—Azathioprine—systemic scleroderma	0.01	0.01	CcSEcCtD
Bisacodyl—Syncope—Captopril—systemic scleroderma	0.00994	0.00994	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00976	0.00976	CcSEcCtD
Bisacodyl—Loss of consciousness—Captopril—systemic scleroderma	0.00974	0.00974	CcSEcCtD
Bisacodyl—Immune system disorder—Leflunomide—systemic scleroderma	0.00948	0.00948	CcSEcCtD
Bisacodyl—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00943	0.00943	CcSEcCtD
Bisacodyl—Malnutrition—Leflunomide—systemic scleroderma	0.00913	0.00913	CcSEcCtD
Bisacodyl—Anaphylactic shock—Captopril—systemic scleroderma	0.00904	0.00904	CcSEcCtD
Bisacodyl—Shock—Captopril—systemic scleroderma	0.0089	0.0089	CcSEcCtD
Bisacodyl—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00879	0.00879	CcSEcCtD
Bisacodyl—Muscle spasms—Leflunomide—systemic scleroderma	0.00878	0.00878	CcSEcCtD
Bisacodyl—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00871	0.00871	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00842	0.00842	CcSEcCtD
Bisacodyl—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00838	0.00838	CcSEcCtD
Bisacodyl—Angioedema—Leflunomide—systemic scleroderma	0.00835	0.00835	CcSEcCtD
Bisacodyl—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00817	0.00817	CcSEcCtD
Bisacodyl—Abdominal pain—Mometasone—systemic scleroderma	0.00814	0.00814	CcSEcCtD
Bisacodyl—Dizziness—Pentoxifylline—systemic scleroderma	0.00789	0.00789	CcSEcCtD
Bisacodyl—Malnutrition—Lisinopril—systemic scleroderma	0.00785	0.00785	CcSEcCtD
Bisacodyl—Syncope—Mycophenolic acid—systemic scleroderma	0.00781	0.00781	CcSEcCtD
Bisacodyl—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00766	0.00766	CcSEcCtD
Bisacodyl—Vomiting—Pentoxifylline—systemic scleroderma	0.00759	0.00759	CcSEcCtD
Bisacodyl—Muscle spasms—Lisinopril—systemic scleroderma	0.00755	0.00755	CcSEcCtD
Bisacodyl—Headache—Pentoxifylline—systemic scleroderma	0.00748	0.00748	CcSEcCtD
Bisacodyl—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00745	0.00745	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Captopril—systemic scleroderma	0.0074	0.0074	CcSEcCtD
Bisacodyl—Nervous system disorder—Leflunomide—systemic scleroderma	0.00731	0.00731	CcSEcCtD
Bisacodyl—Angioedema—Lisinopril—systemic scleroderma	0.00717	0.00717	CcSEcCtD
Bisacodyl—Abdominal pain—Captopril—systemic scleroderma	0.00715	0.00715	CcSEcCtD
Bisacodyl—Nausea—Pentoxifylline—systemic scleroderma	0.00709	0.00709	CcSEcCtD
Bisacodyl—Diarrhoea—Mometasone—systemic scleroderma	0.00705	0.00705	CcSEcCtD
Bisacodyl—Syncope—Lisinopril—systemic scleroderma	0.00704	0.00704	CcSEcCtD
Bisacodyl—Shock—Mycophenolic acid—systemic scleroderma	0.007	0.007	CcSEcCtD
Bisacodyl—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00697	0.00697	CcSEcCtD
Bisacodyl—Loss of consciousness—Lisinopril—systemic scleroderma	0.0069	0.0069	CcSEcCtD
Bisacodyl—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00688	0.00688	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00681	0.00681	CcSEcCtD
Bisacodyl—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Bisacodyl—Vomiting—Mometasone—systemic scleroderma	0.00655	0.00655	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Bisacodyl—Headache—Mometasone—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00644	0.00644	CcSEcCtD
Bisacodyl—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00641	0.00641	CcSEcCtD
Bisacodyl—Shock—Lisinopril—systemic scleroderma	0.0063	0.0063	CcSEcCtD
Bisacodyl—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00628	0.00628	CcSEcCtD
Bisacodyl—Abdominal pain—Azathioprine—systemic scleroderma	0.00624	0.00624	CcSEcCtD
Bisacodyl—Diarrhoea—Captopril—systemic scleroderma	0.00619	0.00619	CcSEcCtD
Bisacodyl—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Bisacodyl—Nausea—Mometasone—systemic scleroderma	0.00612	0.00612	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.0061	0.0061	CcSEcCtD
Bisacodyl—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Bisacodyl—Dizziness—Captopril—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Bisacodyl—Abdominal pain—Leflunomide—systemic scleroderma	0.00589	0.00589	CcSEcCtD
Bisacodyl—Hypersensitivity—Azathioprine—systemic scleroderma	0.00582	0.00582	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00582	0.00582	CcSEcCtD
Bisacodyl—Vomiting—Captopril—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Bisacodyl—Headache—Captopril—systemic scleroderma	0.00567	0.00567	CcSEcCtD
Bisacodyl—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00562	0.00562	CcSEcCtD
Bisacodyl—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00561	0.00561	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00553	0.00553	CcSEcCtD
Bisacodyl—Shock—Mycophenolate mofetil—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Bisacodyl—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Bisacodyl—Hypersensitivity—Leflunomide—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Bisacodyl—Diarrhoea—Azathioprine—systemic scleroderma	0.0054	0.0054	CcSEcCtD
Bisacodyl—Nausea—Captopril—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Bisacodyl—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Bisacodyl—Dizziness—Azathioprine—systemic scleroderma	0.00522	0.00522	CcSEcCtD
Bisacodyl—Diarrhoea—Leflunomide—systemic scleroderma	0.0051	0.0051	CcSEcCtD
Bisacodyl—Abdominal pain—Lisinopril—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Bisacodyl—Vomiting—Azathioprine—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Bisacodyl—Headache—Azathioprine—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Bisacodyl—Dizziness—Leflunomide—systemic scleroderma	0.00493	0.00493	CcSEcCtD
Bisacodyl—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Bisacodyl—Immune system disorder—Prednisone—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Bisacodyl—Vomiting—Leflunomide—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Bisacodyl—Hypersensitivity—Lisinopril—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Bisacodyl—Dizziness—Mycophenolic acid—systemic scleroderma	0.0047	0.0047	CcSEcCtD
Bisacodyl—Nausea—Azathioprine—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Bisacodyl—Headache—Leflunomide—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Bisacodyl—Malnutrition—Prednisone—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Bisacodyl—Vomiting—Mycophenolic acid—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Bisacodyl—Headache—Mycophenolic acid—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Bisacodyl—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Bisacodyl—Nausea—Leflunomide—systemic scleroderma	0.00443	0.00443	CcSEcCtD
Bisacodyl—Diarrhoea—Lisinopril—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Bisacodyl—Angioedema—Prednisone—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Bisacodyl—Dizziness—Lisinopril—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Bisacodyl—Nausea—Mycophenolic acid—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Bisacodyl—Syncope—Prednisone—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Bisacodyl—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Bisacodyl—Loss of consciousness—Prednisone—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Bisacodyl—Vomiting—Lisinopril—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Bisacodyl—Immune system disorder—Methotrexate—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Bisacodyl—Headache—Lisinopril—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Bisacodyl—Malnutrition—Methotrexate—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Bisacodyl—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Bisacodyl—Nausea—Lisinopril—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Bisacodyl—Anaphylactic shock—Prednisone—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Bisacodyl—Shock—Prednisone—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Bisacodyl—Nervous system disorder—Prednisone—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Bisacodyl—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Bisacodyl—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Bisacodyl—Headache—Mycophenolate mofetil—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Bisacodyl—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Bisacodyl—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Bisacodyl—Nervous system disorder—Methotrexate—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Bisacodyl—Abdominal pain—Prednisone—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Bisacodyl—Hypersensitivity—Prednisone—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Bisacodyl—Diarrhoea—Prednisone—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Bisacodyl—Dizziness—Prednisone—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Bisacodyl—Abdominal pain—Methotrexate—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Bisacodyl—Vomiting—Prednisone—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Bisacodyl—Headache—Prednisone—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Bisacodyl—Hypersensitivity—Methotrexate—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Bisacodyl—Nausea—Prednisone—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Bisacodyl—Diarrhoea—Methotrexate—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Bisacodyl—Dizziness—Methotrexate—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Bisacodyl—Vomiting—Methotrexate—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Bisacodyl—Headache—Methotrexate—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Bisacodyl—Nausea—Methotrexate—systemic scleroderma	0.00189	0.00189	CcSEcCtD
